[DOI] [PubMed] [Google Scholar] 38.Thomsen R.W., Mailhac A., Lhde J.B., Pottegrd A
The most common phase II drug-metabolizing enzymes are UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), N-acetyltransferases (NATs), glutathione S-transferases (GSTs), methyltransferases (thiopurine S-methyltransferases (TPMTs), catechol O-methyltransferases (COMTs)) and acyltransferases (Jancova et al., 2010
This is expected given their shared GLP-1 receptor agonism, which slows gastric emptying and alters gut motility
The beauty of IV therapy lies in this direct delivery system - no digestive roadblocks, no nutrient loss, just pure beauty fuel heading straight to where your body needs it most
In Sherding RG, editor: The cat: diseases and clinical management, ed 2, New York, 1994, Churchill Livingstone, p 1215
Magro et al